That is big accumulation for the Special Situations group -AWM 527 Madison Ave picking up a boat load of CDMO
Maybe Patrick Crutcher across at 520 Madison Ave with Chimera Research realized how foolish the comments were...and now to green signal all aboard...heck, even Merck on 3 trials now with PS Targeting so they see something very good with the IP
The new Avid BODs have a very unique business model...a full fledged CDMO and milestones royalties Biomarkers etc etc from the PS Targeting IP ( something NO other CDMO has and once fully in motion...the price will Trump all other CDMO buyouts )
Chimera” is actually Patrick Crutcher, who revealed...